CARMAT announced a software enhancement which significantly improves the safety profile of its Aeson®? artificial heart. The prosthesis software will now be able to detect on a real time basis, signals of possible Aeson®?

faults. The software will then immediately adapt the control of the prosthesis so that its performance is not affected, and the patient's support is not impacted. These changes, developed and tested by CARMAT's research teams, will first be deployed on all hearts currently implanted in patients, as part of a software update for which a field safety notice is published.

It will then be embedded into the Aeson®? production process, after getting the appropriate regulatory approvals.